Connect with us

Health

How a South African Hospital Team Pioneered the World’s First AI-Powered Cancer Treatment Revolution

Digital Healing: How Bloemfontein Became Ground Zero for the AI Cancer Treatment Revolution

Joe Jacob

Published

on

Cancer jpeg
Illustrative image for representative purpose/EdPublica

The University of the Free State (UFS), South Africa, and Universitas Academic Hospital have achieved a global healthcare milestone by becoming the first clinical site worldwide to successfully integrate artificial intelligence into cancer treatment planning, marking a transformative advancement in oncology care, according to a statement issued by UFS.

AI implementation

The Departments of Medical Physics and Oncology at UFS, in partnership with Universitas Academic Hospital, have implemented the Radiation Planning Assistant (RPA), a sophisticated web-based AI platform developed by MD Anderson Cancer Center in Houston, Texas. This pioneering initiative has already treated nearly 50 patients, positioning the Bloemfontein-based teams as global leaders in the clinical application of AI in radiotherapy.

Under the leadership of Dr. William Shaw, Senior Lecturer and Deputy Manager in the Department of Medical Physics, the institution has built a robust academic partnership with Professor Laurence Court and his team at MD Anderson Cancer Center—a collaboration that is now yielding remarkable real-world results.

“The introduction and clinical integration of the RPA at the UFS and Universitas Hospital represents a major advancement for oncology services—both regionally and nationally,” Dr. Shaw explained. “It signifies the transition from research collaboration to real-world application, where artificial intelligence is being used to improve access to safe, high-quality cancer care.”

Revolutionizing treatment planning

The RPA technology addresses one of the most time-consuming aspects of cancer care: creating patient-specific radiation treatment plans. The cloud-based platform automates critical components of the treatment planning process, enabling consistent production of high-quality radiotherapy plans while reducing demands on specialized clinical staff.

Dr. Shaw described the streamlined process: “The process begins with the acquisition of a planning CT scan, which serves as the sole imaging input to the RPA. Once the CT dataset has been captured, it is uploaded to the RPA platform via a secure web interface.”

The system uses advanced machine learning algorithms to automatically identify and delineate both tumour volumes and critical normal tissues. Following the completion of the contouring process, the platform automatically generates a comprehensive radiotherapy treatment plan.

Expanding treatment applications

Initially implemented for cervix cancer treatment—representing the largest proportion of radiotherapy patients at the institution—the RPA has since expanded to encompass breast cancer, head and neck cancers, and primary brain tumors. With ongoing institutional support, the system shows significant promise for broader application across nearly all major tumor types treated with external beam radiotherapy.

Professor Vasu Reddy, Deputy Vice-Chancellor for Research and Internationalisation at UFS, praised the achievement: “We extend our congratulations to our colleagues for their exemplary collaborative achievements. Your pioneering work represents the transformative power of multidisciplinary research in advancing medical science and improving patient outcomes.”

Immediate patient benefits

The technology delivers immediate, meaningful improvements for cancer patients by enabling faster access to well-constructed, evidence-based treatment plans reviewed and refined by experts. This translates to more timely care, fewer unplanned treatment interruptions, and improved protection of normal tissues, resulting in fewer side effects and better overall outcomes.

“Our aim is to use artificial intelligence not as a shortcut, but as a tool to standardize, scale, and improve cancer care in places where the need is greatest,” Dr. Shaw emphasized. “The RPA enhances the quality, consistency, and timeliness of cancer treatment in radiotherapy settings—particularly in environments where clinical capacity is limited.”

International expansion

The success in Bloemfontein serves as a model for broader health system innovation, providing a foundation for the safe, phased rollout of similar systems in other provinces. Professor Court has already extended access to the RPA to other radiotherapy centers in South Africa, with expansion to additional countries planned for the near future.

The Department of Oncology, led by Professor Alicia Sherriff, has joined the initiative as an active clinical partner, establishing a multi-disciplinary collaboration that lays the foundation for further research and innovation at the intersection of medical physics, oncology, and data science.

Advanced treatment techniques

Beyond external beam radiotherapy, the UFS and Universitas teams are advancing the use of interstitial brachytherapy for cervix cancer. While not the first globally to implement this specialized technique, the Bloemfontein team ranks among the earliest adopters on the African continent, helping expand access to this advanced modality where it’s most needed.

Future vision

This work received support from the Nuclear Technologies in Medicine and the Biosciences Initiative (NTeMBI), a national technology platform developed and managed by the South African Nuclear Energy Corporation (Necsa) and funded by the Technology Innovation Agency (TIA).

Dr. Shaw’s team has played a central role in developing safe, reliable clinical processes to integrate AI tools like the RPA into daily practice, ensuring that automation enhances rather than replaces professional expertise.

Professor Reddy outlined the broader vision, “The future we are heading towards is one where human innovation and digital technologies work together to elevate the standard of care, rather than replace humanity in medicine. It is encouraging to see how our colleagues are internationalizing our footprint, together with machine precision to enhance detection, personalize treatment and, perhaps importantly, empowering clinicians with data-driven insights for patient care.”

This innovation represents a significant step forward for cancer care in South Africa and demonstrates how international partnerships can bring cutting-edge technologies to healthcare frontlines, making them work effectively in real clinics for real patients. As cancer incidence rises across low- and middle-income countries, the leadership shown by the UFS and Universitas teams offers a compelling model for how academic medical centers can respond with agility, scientific rigor, and global solidarity.

Edited by Chris Jose

Health

What is the Mysterious ‘Egoviruses’ in the Guts of 180 Million People

Scientists have discovered egoviruses, a previously unknown group of gut viruses potentially present in 180 million people worldwide. Their genetic connection to poxviruses could offer new clues about viral evolution.

Published

on

Colourful artistic illustration of virus-like particles in yellow and magenta against a black background, used to accompany a report on the discovery of egoviruses in human and animal gut samples.
A recent study identified a previously unknown group of gut-associated viruses called egoviruses, with close evolutionary links to poxviruses. Representational image. Image credit: Merlin Lightpainting/ Pexels

Millions of people could be carrying a previously unknown group of disease-causing viruses in their digestive systems without ever knowing it. Scientists have now identified these microbes, named ‘egoviruses’, in human and animal gut samples, uncovering a surprising connection to one of the most important families of disease-causing viruses.

The discovery is drawing attention because egoviruses are closely related to poxviruses, the family that includes the viruses responsible for smallpox and mpox. Researchers estimate that these newly identified viruses could be present in around 180 million people worldwide. The findings offer a new perspective on the evolution of viruses and the largely unexplored microbial world inside the human digestive system.

Hidden Viral Population in the Human Gut

The discovery emerged from an extensive examination of genetic material collected from human and animal digestive systems. Rather than isolating individual viruses in laboratories, researchers used metagenomics, a technique that allows scientists to identify organisms by analysing genetic material in biological samples.

Scientific figure showing the evolutionary relationships of egoviruses and poxviruses, comparisons of viral protein structures, and the distribution of viral genes across single-celled organisms found in human and animal digestive systems.
Scientific analysis of egovirus genomes reveals their evolutionary relationship with poxviruses and genetic similarities with viruses found in single-celled organisms living in animal digestive systems. Source: Nature research study.

The research team, led by microbial ecologist Tom Delmont of the French National Centre for Scientific Research, identified egoviruses across samples from several countries. These included Tanzania, Nepal, Fiji, the United States and parts of Europe.

The analysis revealed six distinct groups associated with humans. One of these groups was found across multiple continents, suggesting that the viruses are not confined to a particular population or geographical region. The researchers also detected egoviruses in buffaloes, goats, chickens, deer and pigs. Their presence across different animal species points to a much wider distribution than scientists had previously recognised.

Do These Viruses Actually Infect Humans?

If egoviruses are found in human gut samples, does that mean they infect human cells? Not necessarily. The researchers suspect that these viruses may target single-celled organisms living in the digestive tract rather than human cells themselves. Genetic comparisons revealed similarities between egovirus genes and those of two groups of single-celled organisms, Parabasalia and Trichostomatia.

Some members of these groups live in animal digestive systems. Trichostomatia, for example, includes microorganisms found in the digestive tracts of ruminants, where they are involved in breaking down food. This could mean that the human gut contains viruses that interact with its microbial inhabitants rather than directly attacking human tissue. However, researchers have yet to confirm their suspected hosts through direct experiments. There is also no evidence from this study that egoviruses cause illness in humans.

Surprising Link to Smallpox and Mpox Viruses

Perhaps the most intriguing aspect of the discovery lies in the evolutionary history of egoviruses. The researchers found that these viruses are the closest known relatives of poxviruses among the groups they examined. Poxviruses are large DNA viruses that can infect humans and animals. Smallpox, eradicated in 1980, and mpox belong to this family.

The genetic relationship has led researchers to investigate whether the ancestors of poxviruses once infected single-celled organisms before evolving the ability to infect animal cells. One possibility is that an ancestral virus initially lived among microorganisms in the digestive systems of early animals. Over millions of years, evolutionary changes may have enabled some descendants to infect animal cells directly.

This remains a hypothesis, rather than a confirmed account of how poxviruses originated. Nevertheless, egoviruses offer scientists a previously unknown group of viruses through which to investigate that evolutionary transition.

What Scientists Still Need to Find Out

The discovery adds another layer to the growing understanding of the human gut, which hosts a complex community of bacteria, fungi, viruses and other microorganisms. But identifying a virus is only the beginning. Scientists still need to establish which organisms egoviruses infect, how they behave inside the gut and whether they influence the wider microbial community.

For now, the discovery of a virus group potentially carried by 180 million people raises a fascinating possibility, a large part of the human body’s viral diversity may have remained hidden simply because scientists had not yet known where to look.

Continue Reading

Health

India’s medical students show interest in research, but mentorship and institutional support remain major hurdles

A new review highlights the barriers facing Indian medical students pursuing research, including inadequate mentorship, limited funding and insufficient institutional support, despite strong student interest.

Published

on

Undergraduate medical students in white coats conducting laboratory work using microscopes.
Medical students participate in a laboratory practical session, highlighting the importance of hands-on scientific training and research exposure in medical education.Image credit:Pixels

Indian medical students recognise the importance of research in strengthening healthcare, but many struggle to translate that interest into actual research projects and publications. Limited faculty mentorship, inadequate funding, insufficient research training and the pressure of academic workloads continue to restrict undergraduate research participation, according to a review published in Frontiers in Medicine on November 13, 2026.

The review, titled Understanding Research Orientation and Practice Among Undergraduate Medical/Dental Students in India: Challenges, Barriers and Enablers examines existing studies on undergraduate research engagement and evaluates national initiatives intended to develop research capabilities among medical and dental students.

The findings point to a gap between students’ willingness to pursue research and the institutional support available to help them do so.

Research interest does not translate into participation

A 2024 cross-sectional study involving 606 Indian medical students found that awareness of research opportunities did not necessarily translate into completed projects.

Although 77.23% of respondents knew about the Indian Council of Medical Research’s (ICMR) Short-Term Studentship (STS) programme, only 16.34% had applied. Just 6.4% completed their research within the prescribed period, while only 1.98% published their ICMR-related findings.

The study also examined students’ access to academic guidance. While 65.35% approached faculty members for assistance, only 46.53% found them helpful. Just 33.17% received assistance from senior students.

The findings suggest that awareness campaigns alone may not be sufficient to develop a research culture without accessible mentorship and sustained institutional support.

The 2026 review also highlights findings from individual medical colleges. At ESIC Medical College, Chennai, a study involving 241 students found that only 8.3% actively participated in research, despite 60% recognising its importance in clinical care.

At Pushpagiri Institute of Medical Sciences and Research Centre in Kerala, a study of 160 undergraduate students and interns found that 96.9% recognised the value of research, but only 12.5% had participated in ICMR-STS.

These institution-specific findings illustrate the difference between research awareness and actual engagement.

A wider institutional research gap

The challenge extends beyond undergraduate classrooms. A study examining research output across 579 Indian medical institutions, cited in a 2026 research paper, found that 57.3% had no publications.

The finding raises questions about the research environment in medical institutions and the opportunities available to students who want to participate in scientific investigation.

However, some institutions have demonstrated that structured mentorship can improve participation.

A study published in BMC Research Notes in April 2026 documented the experience of JIGNYASA, a student-led undergraduate research committee established in February 2020 at a government medical college and tertiary-care hospital in western India.

Between February 2020 and September 2025, the initiative recorded 228 student-initiated research projects, 34 grant approvals and 59 publications.

medical student
research

A medical student examining a report.Image credit:Pexels

The model relied on senior-student mentorship, continuous faculty guidance, research-promotion activities and regular feedback. The authors presented it as a potentially replicable approach for institutions seeking to strengthen undergraduate research without substantial additional funding.

National programmes need stronger implementation

The Frontiers review examines three initiatives: ICMR’s Short-Term Studentship programme, the National Medical Commission’s Community Health Programme and the Basic Course in Biomedical Research.

The STS programme provides undergraduate medical and dental students an opportunity to undertake short-term research under faculty supervision. The Community Health Programme introduces students to field-based health research, while the Basic Course in Biomedical Research provides structured training in research methodology.

However, the review identifies limitations, including inadequate research grants, uneven access to mentors, limited hands-on training and insufficient support for publishing findings.

It argues that medical colleges need to provide dedicated research time, accessible funding, trained faculty mentors and stronger institutional research infrastructure.

For India, developing clinician-researchers is important not only for improving medical education but also for strengthening the country’s capacity to generate evidence relevant to its own healthcare needs.

The evidence suggests that the problem is not simply a lack of interest among medical students. It is the absence of consistent opportunities and institutional structures that can turn that interest into meaningful scientific contributions.

Continue Reading

Health

Six months on, Ebola outbreak in DR Congo remains uncontrolled, with over 5,500 deaths

Six months after its declaration, the Ebola outbreak in DR Congo remains uncontrolled, with over 5,500 deaths. Armed conflict, gaps in disease surveillance and limited healthcare access continue to hamper containment efforts as the Bundibugyo virus spreads across eight provinces.

Published

on

A healthcare worker wearing protective gloves administers an injection into a patient's upper arm.
A participant in the eastern DR Congo receives a vaccine as part of a trial to tackle the Ebola Bundibugyo virus.Image credit: WHO

Six months after the Democratic Republic of the Congo (DRC) declared an Ebola outbreak, the disease remains out of control, with more than 11,300 confirmed cases and 5,500 deaths reported in the country. Despite an expanded international response, the outbreak continues to spread amid armed conflict, displacement and weaknesses in healthcare delivery.

The Africa Centres for Disease Control and Prevention (Africa CDC) warned on November 15 that the outbreak was still not under control. Its Director-General, Jean Kaseya, cautioned that unless transmission is interrupted, the epidemic could become the world’s worst Ebola outbreak.

According to the European Centre for Disease Prevention and Control (ECDC), the DRC had recorded 11,376 confirmed infections and 5,568 deaths as of November 15, based on data up to November 14. Eight provinces have been affected, with Ituri reporting the highest burden. The outbreak is caused by the Bundibugyo virus, a relatively rare species of Ebola virus.

Delayed detection is driving transmission

One of the biggest obstacles to containment is the inability to identify infected people and their contacts early. According to Africa CDC, more than 80% of new infections are being detected among people who were not previously listed as contacts of confirmed patients.

Contact tracing is central to Ebola control. Once an infection is confirmed, health workers identify people who may have been exposed and monitor them for symptoms during the 21-day incubation period. Failure to identify these contacts creates opportunities for further transmission.

More than 65% of deaths have occurred in communities rather than healthcare facilities, indicating that many patients are being identified too late to receive timely treatment. The World Health Organization (WHO) reported that children account for more than a quarter of confirmed infections and approximately one-third of deaths. Seven in 10 children under five who contract the disease have died.

The outbreak has expanded to 67 health zones across eight provinces, with an estimated 400–500 new cases being reported each week, according to the WHO’s November 14 update.

Conflict and insecurity disrupt response

Armed conflict and population displacement have further complicated containment. Insecurity has restricted access to affected communities, disrupted healthcare services and made surveillance and contact tracing difficult.

The WHO reported more than 80 attacks on healthcare since the outbreak began. An armed attack in Cantine-Aloya killed 66 civilians, including three health workers, while three healthcare facilities were looted. More than 1,000 contacts were subsequently lost to follow-up, and three confirmed patients could not be accounted for.

The response has also been affected by delayed payments to frontline health workers. Africa CDC has warned that inadequate resources, insufficiently trained personnel and operational difficulties are weakening efforts to contain the disease.

Ebola outbreak
six months

To help fight the spread of Ebola, UNICEF is supporting District Health Educators (DHE) in high-risk districts to conduct outreach activities with different groups, including corporate and business sectors, educational facilities, prisons, hostels and guest-houses. Photo: UNICEF/UNI790701/Bamulanzeki

Healthcare capacity expands, but gaps persist

There has been progress in strengthening the response. According to the WHO, diagnostic capacity has increased from two laboratories to more than two dozen, while nearly 2,000 treatment beds have been made available across 104 treatment and transit centres.

More than 17,000 community health workers and 46,000 community actors have received training to support surveillance, contact tracing and public awareness. Nearly 90% of registered deaths are now being managed through safe and dignified burials, reducing the risk of transmission during funerals.

However, these improvements have not translated into nationwide containment. Several initial outbreak centres, including Butembo, Mongbwalu and Nyankunde, have brought transmission under control, but new infections continue to emerge elsewhere.

The challenge of containing Bundibugyo virus

The virus itself presents another challenge. Bundibugyo is distinct from the Zaire ebolavirus responsible for the 2014–2016 West African epidemic. Vaccines developed against the Zaire species cannot be assumed to protect against Bundibugyo virus. There is currently no licensed vaccine specifically approved against this strain.

The international response therefore continues to depend on early diagnosis, isolation, supportive treatment, infection prevention and safe burial practices, alongside research into candidate vaccines and treatments.

The WHO has called for sustained, flexible funding through 2027 and improved access to communities affected by conflict. The outbreak has also prompted stronger cross-border surveillance, following infections reported in Kenya and Nigeria.

Six months into the crisis, the challenge is no longer simply mobilising an emergency response. It is ensuring that diagnostic services, trained personnel and treatment reach communities where transmission continues. Without sustained funding, improved security and effective contact tracing, the outbreak could remain a regional public health threat.

Continue Reading

Trending